Transplantation Market to Exhibit a CAGR of 9.7% from 2024 to 2032; LiveOnNY Partners with MediGO to Launch Real-Time Organ Tracking Technology

The global transplantation market size stood at USD 10.11 billion in 2023. The market value is slated to rise from USD 10.96 billion in 2024 to USD 22.94 billion by 2032 at a CAGR of 9.7% during 2024-2032. Fortune Business Insights™ presents this information in its report titled “Transplantation Market Size, Share & Industry Analysis, By Product Type (Tissue Products, Immunosuppressive Drugs, and Preservation Solutions), By Application (Organ Transplantation and Tissue Transplantation), By End-user (Hospitals, Transplantation Centers, and Others), and Regional Forecast, 2024-2032”.

Transplantation is a surgical procedure, where elimination of an organ or a living tissue and implanting it to another body or another body’s part takes place. The growing demand for these procedures, coupled with the release of novel products for the prevention of failure of these procedures is impelling market expansion.

The global market was influenced by the COVID-19 pandemic on account of a decrease in transplantation procedures. In addition, the sales of the products of key companies were negatively influenced at the end of 2020. However, the market witnessed a return to the pre-pandemic level due to a surge in awareness about organ donation coupled with an increase in patient visits to hospital settings at the end of 2022.

MemoTherapeutics Secures USD 27.6 Million from Pureos Bioventures for Phase II Trial of AntiBKV

MemoTherapeutics, a Switzerland-based company, received USD 27.6 million from Pureos Bioventures in November 2023 to fund a Phase II trial investigating its candidate AntiBKV. The drug will be used to investigate treatment for BK polyomavirus (BKV) infection in kidney transplant patients.

Market Value to Rise Owing to Technological Innovations in Tissue Products

One of the key factors propelling the transplantation market growth is the development of the technology of tissue products. Autologous stem cell transplant is one of the emerging technologies in tissue products, which has become convenient owing to the arrival of induced Pluripotent Stem Cells (iPSC). In addition, novel technologies, including decellularization and recellularization, interspecies organogenesis, and three-dimensional (3D) bioprinting, are being deployed to overcome immunologic hurdles.

Despite such growth opportunities, the unawareness of alternatives for these procedures in developing nations may impede market expansion.

Top Players Focus on Partnerships to Provide Enhanced Solutions

Market players are emphasizing strategic acquisitions and new product launches to obtain the largest share of the market. In the immunosuppressive drugs segment, Astellas captures a dominating position with a highly successful PROGRAF (tacrolimus) product. In addition, BioLife Solutions is one of the prominent players with respect to preservation solutions owing to its strong cell processing segment, which includes biopreservation media products. A wide array of strategies, such as joint ventures, capacity expansions, and product innovations, are being focused on by leading players to keep ahead of their competition. Partnership strategies are also being prioritized by some prominent players to deliver enhanced solutions.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/transplantation-market-105049

List of Key Players Profiled in the Report:

• Novartis AG (Switzerland)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Arthrex, Inc. (U.S.)
• Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation) (U.S.)
• BioLife Solutions (U.S.)
• TransMedics (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Zimmer Biomet (U.S.)
• Astellas Pharma Inc. (Japan)

Key Industry Development

• March 2023: LiveOnNY announced a collaboration with MediGO and released a real-time organ tracking technology to monitor organ donation and transplantation ecosystem.

Further Report Findings:

• North America is expected to secure the largest transplantation market share during the forecast period bolstered by the quick uptake of three-dimensional (3D) bioprinting across the region.
• Europe’s market obtained the second-largest position in 2023 on account of a surge in transplantation procedures.
• Asia Pacific market registered significant growth in 2023 on the back of the surging incidence of chronic disorders among geriatric pollution, which has led to considerably high cases of organ failure.

Table of Segmentation